What Happens If Your Mounjaro Prescription Is Declined or Discontinued?

You have done the research. You have decided Mounjaro (Tirzepatide) is the right treatment for you. Then you get the message: your Mounjaro (Tirzepatide) prescription has been declined. Or perhaps you have been taking it for months and your provider has told you they can no longer supply it. Either way, you are stuck in the same place, wanting to lose weight and unsure what to do next.

This happens more often than most people expect. NHS eligibility criteria for Mounjaro (Tirzepatide) are strict, private providers sometimes run into supply problems, and individual health profiles do not always fit the prescribing guidelines for tirzepatide. The good news is that a declined Mounjaro (Tirzepatide) prescription does not mean the end of your weight loss journey. There are other prescription weight loss treatments UK patients can access right now, and some of them may actually suit your situation better.

Why Mounjaro (Tirzepatide) Prescriptions Get Declined in the UK

Understanding why your prescription was refused is the first step toward finding the right alternative. The reasons fall into a few common categories.

NHS Eligibility Thresholds

Since Mounjaro (Tirzepatide) became available through primary care in June 2025, NHS prescribing criteria have been strict. To qualify, patients typically need a BMI of 40 or above alongside at least four weight-related health conditions, such as type 2 diabetes, high blood pressure, raised cholesterol, cardiovascular disease, or obstructive sleep apnoea. Patients from South Asian, Chinese, Black African, and Afro-Caribbean backgrounds qualify at a BMI 2.5 points lower, in line with NICE guidance.

That leaves a large number of people with a BMI between 27 and 39 who are clinically overweight, experiencing real health consequences, and still unable to access Mounjaro (Tirzepatide) through the NHS.

Medical Contraindications

Tirzepatide is not suitable for everyone. If you have a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal conditions like gastroparesis, your prescriber will not approve Mounjaro (Tirzepatide).

Pregnancy, breastfeeding, and certain pancreatic conditions also rule it out. These are clinical safety decisions, not bureaucratic ones.

Supply and Cost Issues

Although the major Mounjaro (Tirzepatide) shortage of 2024-2025 has largely resolved, localised supply disruptions still occur. Some pharmacies run out of specific dose strengths, and patients mid-titration can find themselves unable to get the next step up. On the private side, Mounjaro (Tirzepatide) has become more expensive through 2026, pushing some patients toward alternatives that offer similar results at lower cost.

What to Do Immediately After a Decline

A declined prescription is frustrating, but it is not a dead end. Here is what to do next.

First, ask your prescriber for the specific reason. Was it a BMI threshold issue? A medical contraindication? A supply problem? The answer determines which path forward makes the most sense.

Second, request a written summary of the clinical reasoning. If you plan to seek a second opinion or consult a private clinic, having your medical history and the reason for decline documented saves time and avoids repeating tests.

Third, do not try to source Mounjaro (Tirzepatide) without a prescription. Unregulated online sellers and social media resellers are a real problem in the UK market right now. Counterfeit tirzepatide pens have been seized by the MHRA, and injecting unverified medication carries serious health risks. If you want to buy prescribed weight loss medication UK regulations require a legitimate clinical assessment first.

Mounjaro (Tirzepatide) Weight Loss Treatment Alternatives That Actually Work

Being declined for Mounjaro (Tirzepatide) does not mean settling for something less effective. Several prescription weight loss treatments UK clinicians prescribe deliver strong results, and the best option depends on your health profile, your budget, and whether you prefer injections or tablets.

Wegovy (Semaglutide)

Wegovy (Semaglutide) is the closest alternative to Mounjaro (Tirzepatide) by mechanism and results. It targets GLP-1 receptors (Mounjaro (Tirzepatide) targets both GLP-1 and GIP), and the newer 7.2 mg dose produces average weight loss of around 20%, which is close to Mounjaro (Tirzepatide)'s clinical trial figures. Wegovy (Semaglutide) is available through some NHS specialist services, though access varies by region. Private clinics can prescribe it with fewer eligibility barriers than the NHS.

Saxenda (Liraglutide)

Saxenda is a daily GLP-1 injection rather than a weekly one. It produces moderate weight loss, typically 5 to 10% of body weight, and has been available in the UK longer than either Mounjaro (Tirzepatide) or Wegovy (Semaglutide). It is often a good entry point for patients who want to try injectable treatment before committing to the newer, more potent options. Availability has been inconsistent recently, so check with your provider.

Phentermine

If you prefer tablets over injections, phentermine is one of the most widely prescribed appetite suppressants in the UK. It works differently from GLP-1 medications, increasing norepinephrine to reduce hunger signals and boost energy. Phentermine is prescribed for short-term use alongside a structured diet and exercise plan, and it requires regular clinical monitoring including blood pressure checks.

Looking for phentermine online UK? At Weight Medics, phentermine is only prescribed after a doctor-led video consultation to confirm it is clinically appropriate for you. No questionnaire-only prescriptions, no shortcuts.

Mysimba (Naltrexone/Bupropion)

Mysimba combines two medications that target brain pathways involved in appetite and cravings. It is particularly useful for patients whose weight gain is linked to emotional eating or food-related reward behaviours. Results are modest compared to GLP-1 injections, but for the right patient profile it provides a meaningful treatment option without injections.

Orlistat

Orlistat works by blocking fat absorption in the gut rather than suppressing appetite. It is one of the oldest prescription weight loss treatments UK doctors can offer and is available on the NHS. Weight loss tends to be moderate, around 2 to 3% beyond diet and exercise alone, but it suits patients who cannot take stimulant-based or hormonal medications.

Phentermine vs Mounjaro (Tirzepatide): Understanding the Differences

This is one of the most common comparisons patients ask about, especially after a Mounjaro (Tirzepatide) prescription has been declined. The two medications work in completely different ways, and understanding that difference helps you set realistic expectations.

Mounjaro (Tirzepatide) is a dual GIP and GLP-1 receptor agonist. It mimics gut hormones that regulate appetite and blood sugar, producing average weight loss of 15 to 22% of body weight in clinical trials. It is a weekly injection with a gradual titration schedule.

Phentermine is a sympathomimetic amine, a stimulant that suppresses appetite by increasing norepinephrine. It is taken as a daily tablet, usually for 8 to 12 weeks at a time, and produces average weight loss of around 5 to 8% of body weight.

On paper, Mounjaro (Tirzepatide) produces greater weight loss. But that comparison misses context. Phentermine is significantly cheaper, requires no injections, and starts working almost immediately rather than needing months of dose titration. For patients who need to lose a moderate amount of weight, or who want a treatment that fits within a shorter timeframe, phentermine can be the more practical choice.

The ideal scenario is having a clinician who can assess both options and prescribe whatever your body actually needs. That is the advantage of a multi-treatment clinic over a provider that only offers one medication.

How to Find the Right Treatment After a Decline

The best alternatives to Mounjaro (Tirzepatide) UK patients can access depend on where you look and what kind of clinical support you get.

A GP can prescribe orlistat and refer you to specialist weight management services, which may offer Wegovy (Semaglutide) or Mounjaro (Tirzepatide) under NHS criteria. Wait times vary, and eligibility thresholds are high.

Private clinics offer faster access and a broader range of medications. The key is choosing a clinic that offers multiple treatment options rather than just one. If a provider only sells Mounjaro (Tirzepatide) or only sells phentermine, they are going to prescribe you what they have, not necessarily what suits you best.

At Weight Medics, we prescribe across the full range of licensed weight loss medications: Mounjaro (Tirzepatide), Wegovy (Semaglutide), Saxenda, phentermine, diethylpropion, Mysimba, and orlistat. Every treatment starts with a doctor-led consultation. If one medication is not right for you, we do not send you away. We find the one that is.

When Mounjaro (Tirzepatide) Is Discontinued Mid-Treatment

Being declined before starting is one situation. Being taken off Mounjaro (Tirzepatide) after months of treatment is another.

This can happen if your provider loses supply, if your health status changes in a way that makes tirzepatide unsuitable, or if your weight loss has plateaued and your clinician recommends switching. In rarer cases, patients experience side effects that do not resolve with dose adjustments.

If you are discontinuing Mounjaro (Tirzepatide), work with your prescriber to taper gradually where possible. Stopping abruptly can trigger rebound hunger as the appetite-suppressing effects of tirzepatide wear off. Your clinician should help you transition to an alternative treatment or a maintenance plan that prevents regain.

This is one of the key reasons medically supervised programmes outperform DIY approaches. When a treatment stops working or stops being available, there should be a clinical team behind you with a plan, not just a website with a refund policy.

Booking a Weight Loss Consultation: What to Expect

If you are ready to explore alternatives after a Mounjaro (Tirzepatide) decline, here is what a proper consultation should include.

A full medical history review, including why Mounjaro (Tirzepatide) was declined. Your BMI, blood pressure, and any existing health conditions. A discussion of your weight loss goals and timeline. An honest assessment of which treatments you are eligible for, with the pros and cons of each. A prescribing decision made by a qualified doctor, not auto-generated by a questionnaire.

Ready to book a weight loss consultation UK? Weight Medics offers doctor-led video consultations where your full medical picture is reviewed before any medication is prescribed.

As a CQC-registered Weight Loss Clinic UK patients have trusted for over 29 years, we believe a declined prescription should open a conversation, not close one.